Search for: "Michael McGovern" Results 1 - 20 of 100
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
13 Apr 2024, 3:33 pm by admin
Prelude to Litigation Phenylpropanolamine (PPA) was a widely used direct α-adrenergic agonist used as a medication to control cold symptoms and to suppress appetite for weight loss.[1] In 1972, an over-the-counter (OTC) Advisory Review Panel considered the safety and efficacy of PPA-containing nasal decongestant medications, leading, in 1976, to a recommendation that the agency label these medications as “generally recognized as safe and effective. [read post]
15 Mar 2024, 4:00 am by Jim Sedor
Official’s Work for Chinese Client Stirs Concern Over Disclosure Loopholes MSN – Michael Martina (Reuters) | Published: 3/11/2024 Former U.S. [read post]
20 Jul 2022, 5:27 pm
McGovern, the CECC’s Chair and Cochair respectively and CECC Commissioners Senators Marco Rubio (R-FL), Dianne Feinstein (D-CA), Steve Daines (R-MT), Angus King (I-ME), and Tom Cotton (R-AR) and Representatives Christopher Smith (R-NJ), Tom Suozzi (D-NY), Vicky Hartzler (R-MO), Tom Malinowski (D-NJ), and Jennifer Wexton (D-VA).The letter is the end product of a coordinated effort to focus US policy on middle and lower level officials throughout the administrative apparatus that are,… [read post]
5 Nov 2021, 4:00 am by Jim Sedor
Jim McGovern – is going to cut the measure almost in half. [read post]
22 Aug 2021, 6:00 pm by Juvan Bonni
(Source: Cointelegraph)  New Job Postings on Patently-O: AstraZeneca Michael Best & Friedrich LLP – IP Litigation Associate DiBerardino McGovern IP Group Hickman Becker Bingham Ledesma LLP Weaver Austin Villeneuve & Sampson LLP – Patent Prosecution Associate Hanley, Flight & Zimmerman, LLC – Patent Associate Attorney Hanley, Flight & Zimmerman, LLC – IP Docket Specialist Van Pelt, Yi & James LLP Michael Best &… [read post]
8 Jun 2020, 6:33 pm by admin
Councilman Michael Drahos also commended Ron, stating that “he’s done a really great job. [read post]
16 Dec 2019, 6:00 am by Michael Froomkin
Thomas Eagleton notoriously had escaped scrutiny of a his history of ECT therapy, and when that came out days after his being named by George McGovern, Eagleton got dropped from the ticket; the incident torpedoed whatever small chance McGovern had of being elected. [read post]
22 Nov 2019, 5:51 am
Smith, EY Center for Board Matters, on Friday, November 15, 2019 Tags: Boards of Directors, Corporate culture, Corporate Social Responsibility, Disclosure, Diversity, ESG, Human capital, SEC, Securities regulation JV Directors Duty of Loyalty Posted by Meghan McGovern, Tracy Branding, and James Bamford, Water Street Partners LLC, on Saturday, November 16, 2019 Tags: Boards of Directors, Conflicts of… [read post]
4 Apr 2019, 4:46 am by SHG
Mizzou journalism prof Michael Kearney conducted a study that provides a clue. [read post]